Asia Pacific Percutaneous Transluminal Angioplasty Balloons Market Size, Share, Growth, Trends, and Industry Analysis: By Product Type, By Application, By End Users, and Country Forecast 2020-2031
Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Balloons Market size was valued at US$ 4.79 billion in 2024 and is expected to reach US$ 7.45 billion by 2031, growing at a significant CAGR of 6.5% from 2025-2031. Percutaneous Transluminal Angioplasty (PTA) is a process carried to treat the Peripheral Artery Disease (PAD) by opening up the arteries that are narrowed by plaque. Rise in prevalence of coronary and peripheral artery disease, increase in the incidence and prevalence of diabetes, adoption of advanced percutaneous transluminal angioplasty balloons, development in healthcare infrastructure, and better availability of the products are anticiapted to propel the Asia Pacific percutaneous transluminal angioplasty balloons market over the future years.
However, stringent guidelines for product approval, high cost of PTA balloons, and availability of alternative treatment options for peripheral and coronary artery disease may hamper the Asia Pacific percutaneous transluminal angioplasty balloons market.
Asia Pacific percutaneous transluminal angioplasty balloons market is segmented into Japan, China, India, Australia & New Zealand, ASEAN Countries, South Korea, and Rest of Asia Pacific. Japan percutaneous transluminal angioplasty balloons market is driven by increase in the R&D for the innovation of advanced PTA balloons, sophisticated healthcare infrastructure, and availability of skilled professionals. China percutaneous transluminal angioplasty balloons presenting lucrative growth opportunities owing to increase in the prevalence of peripheral and coronary artery disease due to change in lifestyle, rise in adoption of technologically advanced products, and rise in healthcare expenditure are bolster the market. India percutaneous transluminal angioplasty balloons market has prominent share, which is attributed to increase in the medical tourism, entry of companies into the India market, and large patient population.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Market Size in 2024 |
US$ 4.79 billion |
|
Market Size in 2031 |
US$ 7.45 billion |
|
By Product Type |
|
|
By Application |
|
|
By End User |
|
Download Free Sample Report
Asia Pacific percutaneous transluminal angioplasty (PTA) balloons market size was valued at US$ 4.79 billion in 2024 and is expected to reach US$ 7.45 billion by 2031, growing at a significant CAGR of 6.5% from 2025-2031
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
R. Bard, Inc. (U.S.), Cook Medical, Inc. (U.S.), Abbott, Inc. (U.S.), Cardinal Health, Inc. (U.S.), Boston Scientific Corporation (U.S.), Medtronic Plc (Ireland)
| 1.Executive Summary |
| 2.Global Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Balloons Market Introduction |
| 2.1.Global Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Balloons Market - Taxonomy |
| 2.2.Global Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Balloons Market - Definitions |
| 2.2.1. Product Type |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Country |
| 3.Global Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Balloons Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Balloons Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Product Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Drug-Eluting Balloons |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Normal Balloons |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Scoring Balloons |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Cutting Balloons |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Peripheral Artery Disease |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Coronary Artery Disease |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Balloons Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Cardiology Clinics |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Ambulatory Surgical Centers |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Country, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. China |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. India |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Australia and New Zealand (ANZ) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Japan |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Rest of APAC |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. Competition Landscape |
| 9.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 9.2.1.R. Bard, Inc. (U.S.) |
| 9.2.2.Cook Medical, Inc. (U.S.) |
| 9.2.3.Abbott, Inc. (U.S.) |
| 9.2.4.Cardinal Health, Inc. (U.S.) |
| 9.2.5.Boston Scientific Corporation (U.S.) |
| 9.2.6.Medtronic Plc (Ireland) |
| 10. Research Methodology |
| 11. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
